One-year results of a balloon expandable endoprosthesis as a bridging stent for branched endovascular aortic repair

医学 支架 外科 临床终点 队列 气球 放射科 随机对照试验 内科学
作者
Marco Virgilio Usai,Mauro Gargiulo,Stéphan Haulon,Ignace F.J. Tielliu,Dittmar Boeckler,Hence J.M. Verhagen,Alba Méndez Fernández,Martin Austermann
出处
期刊:Journal of Vascular Surgery [Elsevier BV]
卷期号:78 (6): 1376-1382.e2 被引量:9
标识
DOI:10.1016/j.jvs.2023.07.061
摘要

This post-market multicenter registry aimed to evaluate the safety and performance of the GORE VIABAHN VBX balloon expandable endoprosthesis (VBX stent) implanted in peripheral vessels. In this subgroup analysis, we assessed the outcomes of the VBX stent as a bridging stent graft for visceral vessels during branched endovascular aortic repair at 1 year.A single cohort from a prospective, multicenter, observational, 16-site European registry. Patients were enrolled from November 2018 to March 2022. Endpoints included 1-year primary patency (PP), primary assisted patency (PAP), and secondary patency (SP), stent graft-related death and serious adverse events through 30 days.Seventy-three patients were enrolled in this registry sub-cohort, 57 (78.1%) were male, and the mean age was 73 ± 8.1 years. Thoracoabdominal aneurysms predominated the cohort with 68 patients (93.2%), followed by five patients (6.8%) with pararenal and infrarenal aneurysms. Overall, 233 target vessels were treated with the index bridging graft. The overall per stent graft analysis demonstrated a PP of 95.8% at 1 year; PAP was 95.8%, and SP reached 97.9%. The per-target vessel analysis demonstrated a PP, PAP, and SP in the celiac trunk of 100%, 100%, and 100%; in the superior mesenteric artery of 96.0%, 96.0%, and 100%, and in the renal arteries of 94.2%, 94.2%, and 95.1%, respectively. Four patients (5%) died at 1 year; none of the deaths were device-related. The composite endpoint of target vessel technical success and freedom from VBX stent-related serious adverse events through 30 days was achieved in 98.6% of patients.In this prospective post-market multicenter registry, the VBX stent demonstrated excellent results at 1 year, with almost 96% primary patency and 98% secondary patency. Patency in the renal arteries seems to be lower. Nevertheless, the VBX stent appears to be a reliable bridging stent for branched endovascular aortic repair.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
2秒前
科研通AI6.4应助乐橙采纳,获得30
2秒前
3秒前
EastWind应助雪山飞龙采纳,获得10
3秒前
无极微光应助哈哈哈采纳,获得20
4秒前
6秒前
sy完成签到,获得积分10
7秒前
万的饭完成签到,获得积分10
7秒前
9秒前
9秒前
agent发布了新的文献求助10
10秒前
10秒前
CipherSage应助wy采纳,获得10
12秒前
12秒前
cdercder应助陈大浩浩采纳,获得10
13秒前
万的饭发布了新的文献求助10
13秒前
陌欣冉发布了新的文献求助10
14秒前
14秒前
bkagyin应助西格玛游记采纳,获得10
15秒前
16秒前
丘比特应助谨慎的胡萝卜采纳,获得10
16秒前
17秒前
dui发布了新的文献求助10
17秒前
ferrywheel发布了新的文献求助10
17秒前
李恩乐完成签到 ,获得积分10
18秒前
18秒前
18秒前
桐桐应助完美的雁荷采纳,获得10
19秒前
19秒前
fengchao发布了新的文献求助10
20秒前
ayuanpf发布了新的文献求助10
21秒前
22秒前
star发布了新的文献求助10
22秒前
22秒前
sttm完成签到 ,获得积分10
23秒前
23秒前
A砷s发布了新的文献求助20
23秒前
桐桐应助石艾颀采纳,获得10
24秒前
大乐子完成签到,获得积分20
24秒前
24秒前
高分求助中
Principles of Economics, 11th Edition 10000
University Physics with Modern Physics, 16th edition 10000
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Environmental Leverage in Times of Climate Crisis: Product Standards, Carbon Border Measures and Preferential Trade Agreements 1000
Matrix Methods in Data Mining and Pattern Recognition 510
Social Skills Improvement System-Rating Scales--Chinese Version 500
Dynamische Polarisation von H-1 und B-11 in (CH-3)-3NBH-3 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 工程类 有机化学 化学工程 生物化学 计算机科学 内科学 物理 复合材料 催化作用 细胞生物学 无机化学 光电子学 物理化学 电极 基因
热门帖子
关注 科研通微信公众号,转发送积分 7242041
求助须知:如何正确求助?哪些是违规求助? 8866657
关于积分的说明 18704286
捐赠科研通 6915141
什么是DOI,文献DOI怎么找? 3196104
关于科研通互助平台的介绍 2369115
邀请新用户注册赠送积分活动 2170677